© Koninklijke Brill NV, Leiden, 2010 DOI: 10.1163/157180910X12665776638902 European Journal of Health Law 17 (2010) 211-214 brill.nl/ejhl Book Review Michael A. Santoro & Thomas M. Gorrie (Eds.), Ethics and the Pharmaceutical Industry , Cambridge: Cambridge University Press, 2005, pp. 492, ISBN 978-0- 521-70888-3 The starting point for this anthology is what Michael Santoro calls the “unravel- ling of the grand bargain” between the pharmaceutical industry and society. During the most part of the history of the pharmaceutical industry, the com- mercial success of pharmaceutical companies seems to have gone hand-in-hand with enormously increased access in society to many kinds of innovative life- saving and life-enhancing drugs. But as the twenty-ﬁrst century begins, public distrust and resentment of the industry is at an all-time high. Reports and com- plaints ﬂourish about ever-rising drug prices; blatantly misleading advertisement campaigns; the industry’s aggressive stance in trade negotiations with third world countries; and even bribery of physicians to prescribe particular drugs, and of scientists to only publish trials with positive results. All in all, the received opin- ion seems to be that pharmaceutical companies care inﬁnitely more about proﬁts than about people. So how can the public’s trust in the pharmaceutical industry
European Journal of Health Law – Brill
Published: Jan 1, 2010
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera